Reaction Details Report a problem with these data
Target
AP-4 complex subunit sigma-1
Ligand
BDBM484180
Substrate
n/a
Meas. Tech.
Human Sigma-1 Receptor Radioligand Assay
Ki
<100±n/a nM
Citation
Virgili-Bernado, M; Almansa-Rosales, C; Alegret-Molina, C Oxadiazaspiro compounds for the treatment of drug abuse and addiction US Patent US10927128 Publication Date 2/23/2021
More Info.:
Target
Name:
AP-4 complex subunit sigma-1
Synonyms:
AP-4 complex subunit sigma-1 | AP4S1 | AP4S1_HUMAN | Sigma-1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17000.04
Organism:
Homo sapiens (Human)
Description:
Sigma-1 0 HUMAN::Q9Y587
Residue:
144
Sequence:
MIKFFLMVNKQGQTRLSKYYEHVDINKRTLLETEVIKSCLSRSNEQCSFIEYKDFKLIYRQYAALFIVVGVNDTENEMAIYEFIHNFVEVLDEYFSRVSELDIMFNLDKVHIILDEMVLNGCIVETNRARILAPLLILDKMSES
Inhibitor
Name:
BDBM484180
Synonyms:
8-(2-(3-chloropyridin-2- yl)ethyl)-12-isobutyl-4-oxa- 8,12- diazadispiro[2.1.5.3]tridecane | US10927128, Example 101 | US11649248, Example 101
Type:
Small organic molecule
Emp. Form.:
C21H32ClN3O
Mol. Mass.:
377.951
SMILES:
CC(C)CN1CC2(CC2)OC2(CCN(CCc3ncccc3Cl)CC2)C1